- Research works
- 112 ▲ 10% vs 2013–17
- Citations
- 6.1k 54.0 per fractional work
- Top-10% rate
- 12.8% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Zealand Pharma (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 20.2×. Every wedge is a field page.
Which keywords describe research at Zealand Pharma (Denmark)?
By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Heart Failure, Clinical Guidelines, Ion Channels, Cardiovascular Outcomes and Glucose Control.
- Signal Transduction
- Pharmacology
- Enteral Nutrition
- Pancreatic Islets
- Neurological Disorders
- Gap Junctions
- Connexins
- Complications
- Sudden Cardiac Death
- Cardiac Electrophysiology
- Critical Care
- Calcium Signaling
- Channel Regulation
- Diabetes Mellitus
- Arrhythmias
- Glucose Control
- Cardiovascular Disease
- Epidemiology
- Heart Failure
- Insulin Therapy
- Glycemic Control
- Type 2 Diabetes
- Clinical Guidelines
- Ion Channels
- Cardiovascular Outcomes
- Oxidative Stress
- Inflammation
- Astrocyte Function
- Diabetes
- Type 1 Diabetes
- Drug Discovery
- Long-QT Syndrome
- Cell Signaling
- Crystal Structure
- Continuous Glucose Monitoring
- Hypoglycemia
- Obesity
- ß-Cell Dysfunction
- Nutrition Support Therapy
- G-Protein-Coupled Receptors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycemic Control13▲ 83×3 topics
- Insulin Therapy13▲ 103×3 topics
- Type 2 Diabetes8▲ 38×4 topics
- Heart Failure8▲ 15×9 topics
- Clinical Guidelines7▲ 21×3 topics
- Epidemiology7▲ 1.58×24 topics
- Ion Channels7▲ 29×3 topics
- Cardiovascular Disease7▲ 5.5×15 topics
- Cardiovascular Outcomes7▲ 142×1 topic
- Glucose Control7▲ 142×1 topic
- Oxidative Stress7▲ 3.3×14 topics
- Arrhythmias6▲ 44×2 topics
- Inflammation6▲ 2.4×26 topics
- Diabetes Mellitus6▲ 23×5 topics
- Astrocyte Function6▲ 34×2 topics
- Channel Regulation6▲ 55×2 topics
- Diabetes6▲ 10×7 topics
- Calcium Signaling6▲ 39×3 topics
- Type 1 Diabetes6▲ 56×2 topics
- Critical Care6▲ 23×5 topics
- Drug Discovery5▲ 12×3 topics
- Cardiac Electrophysiology5▲ 62×1 topic
- Long-QT Syndrome5▲ 62×1 topic
- Sudden Cardiac Death5▲ 39×2 topics
- Cell Signaling5▲ 14×3 topics
- Complications5▲ 8.5×2 topics
- Crystal Structure5▲ 17×2 topics
- Connexins4▲ 167×1 topic
- Continuous Glucose Monitoring4▲ 81×1 topic
- Gap Junctions4▲ 167×1 topic
- Hypoglycemia4▲ 81×1 topic
- Neurological Disorders4▲ 5.2×4 topics
- Obesity4▲ 4.5×11 topics
- Pancreatic Islets4▲ 47×1 topic
- ß-Cell Dysfunction4▲ 47×1 topic
- Enteral Nutrition3▲ 84×1 topic
- Nutrition Support Therapy3▲ 84×1 topic
- Pharmacology3▲ 9.0×2 topics
- G-Protein-Coupled Receptors3▲ 36×1 topic
- Signal Transduction3▲ 12×1 topic
Which research topics does Zealand Pharma (Denmark) publish most on?
By volume in 2022–2025: Clinical Nutrition and Gastroenterology, Diabetes Treatment and Management, Diabetes Management and Research and Gastrointestinal motility and disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Clinical Nutrition and Gastroenterology Nutrition and Dietetics 2 works
- 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
- 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
- 4 Gastrointestinal motility and disorders Gastroenterology 1 works
- 5 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 1 works
- 6 Cannabis and Cannabinoid Research Pharmacology 1 works
- 7 CRISPR and Genetic Engineering Molecular Biology 0 works
- 8 Gastroesophageal reflux and treatments Gastroenterology 0 works
- 9 Enhanced Recovery After Surgery Surgery 0 works
- 10 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Zealand Pharma (Denmark)'s research output changed?
Output in 2018–2022 was 10% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Copenhagen
- University of Copenhagen
- Rigshospitalet
- Copenhagen Business School
- Copenhagen University Hospital
- Gentofte Hospital
- Bispebjerg Hospital
- Statens Serum Institut
- Novo Nordisk (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.